Suraksha Diagnostic Limited IPO: Issue Price, Listing Gain and Share Price Now
Suraksha Diagnostic Limited listed on 06-Dec-2024 at ₹417.95 against an issue price of ₹441 , a listing change of -5.23%. It last traded at ₹304.9. This page is the record of that issue and what has happened to it since — reported figures only.
Suraksha Diagnostic Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹441 |
| Listing price (listing-day close) | ₹417.95 |
| Listing gain | -5.23% |
| Price now | ₹304.9 |
| Change from issue price | -30.86% |
| Change from listing-day close | -27.05% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Suraksha Diagnostic Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹441 |
| Issue size | ₹846.25 Cr |
| Offer for sale | ₹846.25 Cr |
| Issue opened | 29-Nov-2024 |
| Issue closed | 03-Dec-2024 |
| Listed on | 06-Dec-2024 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | ICICI Securities (left lead) |
How the Suraksha Diagnostic Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 1.74x |
| NII | 1.40x |
| Retail | 0.94x |
| Total | 1.27x |
Suraksha Diagnostic Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹1,574 Cr |
| Trailing P/E | 44.00x |
| Return on capital employed | 17.0% |
| Return on equity | 14.1% |
| 52-week high | ₹334 |
| 52-week low | ₹224 |
| Sector | Healthcare Service Provider |
Fundamentals are as of the desk's last harvest and move with the market.
- Suraksha Diagnostic Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.